UNSPSC 51284502: Aztreonam

This classification denotes a beta-lactam antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G2B4VE5GH8. European Medicines Agency schedules Aztreonam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05664MIG. Aztreonam generally arises in the molecular formula C13H17N5O8S2.

UNSPSC 51284502 Aztreonam is a Commodity code for a specific antibiotic product, but recent state and local procurement activity under this code shows limited direct solicitation for aztreonam alone; instead, issuing bodies are procuring broad pharmaceutical and medical supplies portfolios that may include aztreonam as a line item within larger drug formularies or emergency medical stockpiles. The solicitations characterize what state and local governments actually buy as generic multi-source pharmaceuticals, over-the-counter products, emergency medical supplies, and prescription fulfillment capabilities rather than single-drug purchases. Issuing bodies include state health agencies, county health departments, municipal fire departments, and statewide cooperative purchasing alliances. The work spans contract establishment with pharmaceutical manufacturers and wholesalers, aggregated purchasing through authorized distribution channels, and rapid delivery of medical consumables to support emergency response and community health programs.

Recent activity concentrates in Florida, Minnesota, Texas, and Oregon. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026, due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson) with contract effectiveness July 1, 2026. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, due July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, estimated contract value not disclosed. The City of Tampa issued IFB 26P00145 on March 25, 2026, due March 13, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a 5 percent bid discount set-aside for certified Small Local Business Enterprises. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs, representing early-stage market research rather than a formal competitive solicitation.